Dr. Mark William Sornson, MD

Dr. Sornson practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Sornson's NPI, 1629189550, was assigned on August 31, 2006. Dr. Sornson graduated from UC San Diego School of Medicine in 1998. Dr. Sornson holds California license A69605.

Dr. Sornson's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Sornson's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Dr. Sornson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sornson practices. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Sornson's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Sornson is board certified in dermatology by the American Board of Dermatology. Dr. Sornson is licensed in California.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives, joint cyst and psoriasis among the conditions Dr. Sornson treats.

CMS data shows 2,384 Medicare services from Dr. Sornson across 18 procedure codes in 2024, for 412 Medicare patients. Medicare paid $118,884 for them. Every service was in an office.

CMS counts 412 Medicare patients who saw Dr. Sornson in 2024. The largest group is 65 to 74, with 182 patients. 67% of them have high cholesterol, and 56% have high blood pressure. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sornson's median patient age at 68, with 46% women.

In 2024, Dr. Sornson wrote 489 Medicare Part D claims for 232 patients. 95% of them were for generic drugs. CMS names the drug for 364 of them, across 15 drugs with 11 or more claims each, at $15,298 in total drug cost. In 2023, CMS named 365 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Sornson for performance year 2024, reported as part of a group. Dr. Sornson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sornson as offering telehealth. CMS counts 351 procedures of skin biopsy by Dr. Sornson, more than 92% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Sornson. The most frequent topics are DNA-Binding Proteins, Homeodomain Proteins and Transcription Factor Pit-1. Dr. Sornson's most frequent co-author is Bogi Andersen, MD.

CMS Open Payments shows 110 general payments to Dr. Sornson from 18 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $764.

Dmand AI lists 1 award for Dr. Sornson.

Dr. Sornson graduated from UC San Diego School of Medicine in 1998. Dr. Sornson is a member of AAD.

Dr. Sornson is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.